Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep-frozen vs Room Temperature Platelets for Traumatic Bleeding (MAFOD)
NCT05502809Phase 3Not yet recruiting
- Sponsor
- Alrijne Ziekenhuis
- Start
- Jun 2023
- Primary completion
- Jan 2026
- Modality
- Tissue Cells
01
Overview
A Phase 3 trial of cryopreserved platelets in traumatic hemorrhage, hemorrhage, sponsored by Alrijne Ziekenhuis. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
cryopreserved platelets
03
Conditions
traumatic hemorrhagehemorrhage
Beyond the preview
Go deeper on NCT05502809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05502809.